Free Trial

Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts

Bio-Rad Laboratories logo
$279.48 -6.15 (-2.15%)
As of 02/21/2025 03:58 PM Eastern

Bio-Rad Laboratories Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 6After Market ClosesEstimated
Actual EPS
(Feb. 13)
$2.90 Beat By $0.04
Consensus EPS
(Feb. 13)
$2.86

Bio-Rad Laboratories posted Q4 2024 earnings on February 13, 2025, reporting an EPS of $2.90, which topped analysts' consensus estimates of $2.86 by $0.04. With a trailing EPS of -$65.04, Bio-Rad Laboratories' earnings are expected to grow 15.17% next year, from $10.81 to $12.45 per share.

BIO Upcoming Earnings

Bio-Rad Laboratories' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules.

Get Bio-Rad Laboratories Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bio-Rad Laboratories and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bio-Rad Laboratories Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251$2.29$2.29$2.29
Q2 20251$3.16$3.16$3.16
Q3 20251$2.94$2.94$2.94
Q4 20251$3.16$3.16$3.16
FY 20254$11.55$11.55$11.55
Q1 20261$3.05$3.05$3.05
Q2 20261$3.20$3.20$3.20
Q3 20261$2.89$2.89$2.89

Bio-Rad Laboratories Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2025
(Estimated)
-------
2/13/2025Q4 2024$2.86$2.90+$0.04-$25.57$679.75M-
10/30/2024Q3 2024$1.16$2.01+$0.85-$19.32$628.18M$649.70M
8/1/2024Q2 2024$2.12$3.11+$0.99$82.48$645.79M$638.50M
5/7/2024Q1 2024$2.04$2.29+$0.25-$8.87$619.09M$610.82M
2/15/2024Q4 2023$2.93$3.10+$0.17-$5.94$685.00M$681.18M
10/26/2023Q3 2023$2.87$2.33 -$0.54$1.02$689.50M$632.10M
8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96M$681.10M
5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28M$676.80M

Bio-Rad Laboratories Earnings - Frequently Asked Questions

Bio-Rad Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on BIO's earnings history.

Bio-Rad Laboratories issued an update on its FY 2025 earnings guidance on Thursday, February, 13th. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.

In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $2.90 earnings per share (EPS) to beat the analysts' consensus estimate of $2.86 by $0.04. Learn more on analysts' earnings estimate vs. BIO's actual earnings.

The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online.
Read Transcript

Bio-Rad Laboratories's earnings report can be found in their filing with the SEC.
View SEC filing

Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.57 billion.

Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$1.84 billion. BIO has generated -$65.04 earnings per share over the last four quarters.

Bio-Rad Laboratories's earnings are expected to grow from $10.81 per share to $12.45 per share in the next year, which is a 15.17% increase.

More Earnings Resources from MarketBeat



This page (NYSE:BIO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners